Understanding the Factors That May Influence African American MSM’s Acceptance of a Theoretical HIV Vaccine
Open Access
- 2 January 2026
- journal article
- Published by Taylor & Francis in Behavioral Medicine
- Vol. 52 (1) , 39-49
Abstract
An HIV vaccine is crucial for African American men who have sex with men (MSM) as they are disproportionately impacted by HIV in the United States. Successful vaccine uptake at levels sufficient to protect individuals and reduce transmission requires more than developing an effective HIV vaccine-it necessitates a strong intention to get vaccinated. Understanding the perceptions, attitudes, and concerns surrounding HIV vaccination among African American MSM is essential for healthcare providers and stakeholders to communicate and promote vaccine adoption effectively. Using the Health Belief Model and Extended Parallel Processing Model, the study sought to identify factors that would encourage vaccination among HIV vaccine procrastinators-individuals likely to delay getting the vaccine for more than a year-to uptake a hypothetical HIV vaccine. A cross-sectional study was conducted with 432 African American MSM, 18-64 years, residing in the United States. Multivariable logistic regression analysis examined factors influencing the intention to enhance vaccination among HIV vaccine procrastinators who are at risk for HIV. Vaccine procrastinators are more likely to be older, have a greater fear of HIV stigma, perceive low discrimination when receiving HIV prevention support due to their African American MSM identity, do not use PrEP, and have more significant concerns about vaccine safety compared to non-vaccine procrastinators. The absence of understanding HIV vaccine perceptions represents a missed opportunity to inform and guide healthcare providers and policymakers once an HIV vaccine becomes available.Keywords
Funding Information
- Center for Anti-Racism, Social Justice & Public Health
This publication has 58 references indexed in Scilit:
- Clinical trials and recent progress in HIV vaccine developmentFunctional & Integrative Genomics, 2024
- Projected Life Expectancy Gains From Improvements in HIV Care in Black and White Men Who Have Sex With MenJAMA Network Open, 2023
- Structural Interventions for HIV Prevention and Care Among US Men Who Have Sex with Men: A Systematic Review of Evidence, Gaps, and Future PrioritiesAIDS and Behavior, 2021
- Competing biomedical HIV prevention strategies: potential cost‐effectiveness of HIV vaccines and PrEP in Seattle, WAJournal of the International AIDS Society, 2019
- The future of a partially effective HIV vaccine: assessing limitations at the population levelInternational Journal of Public Health, 2019
- MSM at Highest Risk for HIV Acquisition Express Greatest Interest and Preference for Injectable Antiretroviral PrEP Compared to Daily, Oral MedicationAIDS and Behavior, 2017
- Running Backwards: Consequences of Current HIV Incidence Rates for the Next Generation of Black MSM in the United StatesAIDS and Behavior, 2015
- Sexual Orientation- and Race-Based Discrimination and Sexual HIV Risk Behavior Among Urban MSMAIDS and Behavior, 2014
- Understanding Structural Barriers to Accessing HIV Testing and Prevention Services Among Black Men Who Have Sex with Men (BMSM) in the United StatesAIDS and Behavior, 2014
- HIV Among Black Men Who Have Sex with Men (MSM) in the United States: A Review of the LiteratureAIDS and Behavior, 2013